Trial intelligence / Profile preview

MVI-PK Study: Misoprostol Vaginal Insert PK in Term Pregnancy

NCT01283022Phase 2Completed

Sponsor
Ferring Pharmaceuticals
Start
May 2011
Primary completion
Jul 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of misoprostol in cervical ripening (CR), sponsored by Ferring Pharmaceuticals. Started May 2011; status: completed.

02

Drugs

misoprostol
03

Conditions

cervical ripening (CR)

Beyond the preview

Go deeper on NCT01283022.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01283022.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call